Rodent models of colon carcinogenesis for the study of chemopreventive activity of natural products

Planta Medica

Volumn 74, Issue 13, 2008, Pages 1602-1607

  Femia, Angelo Metro ^a   Caderni, Glovanna ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Chemoprevention; Colon carcinogenesis; Preneoplastic lesions

Indexed keywords

APC PROTEIN; MUCIN;

BAGG ALBINO MOUSE; C57BL 6 MOUSE; CANCER CHEMOTHERAPY; CANCER MODEL; CANCER PREVENTION; COLON CANCER; COLON CARCINOGENESIS; COLON TUMOR; CROHN DISEASE; DRUG ACTIVITY; DRUG EFFICACY; EVALUATION; EXPERIMENTAL MOUSE; EXPERIMENTAL RAT; INSTITUTE FOR CANCER RESEARCH MOUSE; INTESTINE CRYPT; NONHUMAN; ONCOGENE; PATHOGENESIS; REVIEW; SMALL INTESTINE; SPRAGUE DAWLEY RAT; SWISS WEBSTER MOUSE; TUMOR GROWTH; ULCERATIVE COLITIS; WISTAR RAT;

ANIMALS; ANTICARCINOGENIC AGENTS; BIOLOGICAL PRODUCTS; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; MICE; RATS;

ANIMALIA; MUS; RATTUS; RODENTIA;

EID: 56249138667     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1074577     Document Type: Review

References (64)

1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M. Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581-92
2. Hawk ET, Umar A, Viner JL. Colorectal cancer chemoprevention - an overview of the science. Gastroenterology 2004; 126: 1423-47
3. Fearnhead NS, Wilding JL, Bodmer W. Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis. Br Med Bull 2002; 64: 27-43
4. Fearnhead NS, Britton MP, Bodmer WF. The ABC of APC. Hum Mol Genet 2001; 10: 721-33
5. Fodde R, Smits R, Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 2001; 1: 55-67
6. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003; 348: 919-32
7. de la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer 2004; 4: 769-80
8. Feoron ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67
9. Jass JR. Pathogenesis of colorectal cancer. Surg Clin North Am 2002; 82: 891-904
10. Lüchtenborg M, Weijenberg MP, Roemen CM, de Brume AP, van den Brandt PA, Lentjes MH et al. APC mutations in sporadic colorectal carcinomas from The Netherlands Cohort Study. Carcinogenesis 2004; 25: 1219-26
11. Conlin A, Smith G, Carey FA, Wolf CR, Steele RJ. The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma. Gut 2005; 54: 1283-6
12. Lüchtenborg M, Weijenberg MP, Wark PA, Saritas AM, Roemen GM, van Muijen GN et al. Mutations in APC, CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study. BMC Cancer 2005; 5: 160
13. Fenton JI, Hord NG. Stage matters: choosing relevant model systems to address hypotheses in diet and cancer chemoprevention research. Carcinogenesis 2006; 27: 893-902
14. Moser AR, Pilot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990; 247: 322-4
15. Caspar C, Fodde R. APC dosage effects in tumorigenesis and stem cell differentiation. Int J Dev Biol 2004; 48: 377-86
16. Taketo MM. Mouse models of gastrointestinal tumors. Cancer Sci 2006; 97: 355-61
17. Hinoi T, Akyol A, Theisen BK, Ferguson DO, Greenson JK, Williams BO et al. Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation. Cancer Res 2007; 67: 9721-30
18. Boivin GP, Washington K. Yang K, Ward JM, Pretlow TP, Russell R et al. Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology 2003; 124: 762-77
19. Corpet DE, Pierre F. Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system. Cancer Epidemiol Biomarkers Prev 2003; 12: 391-400
20. Corpet DE, Pierre F. How good are rodent models of Carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men. Eur J Cancer 2005; 41: 1911-22
21. Oshima M, Oshima H, Kitagawa K, Kobayashi M, Itakura C, Taketo M. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc Natl Acad Sci U S A 1995; 92: 4482-6
22. Issa AY, Volate SR, Muga SJ, Nitcheva D, Smith T, Wargovich MJ. Green tea selectively targets initial stages of intestinal Carcinogenesis in the AOM- ApcMin mouse model. Carcinogenesis 2007; 28: 1978-84
23. Paulsen JE, Steffensen IL, Loberg EM, Husoy T, Namork E, Alexander J. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon. Cancer Res 2001; 61: 5010-5
24. Andreassen A, Mollersen L, Vikse R, Steffensen IL, Mikalsen A, Paulsen JE et al. One dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhiP) or 2-amino-3-rnethylimidazo[4,5-f]quinolone (IQ) induces tumours in Min/+ mice by truncation mutations or LOH in the Apc gene. Mutat Res 2002; 517: 157-66
25. Aoki K, Tamai Y, Horiike S, Oshima M, Taketo MM. Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Delta716 Cdx2+/- compound mutant mice. Nat Genet 2003; 35: 323-30
26. Amos-Landgraf JM, Kwong LN, Kendziorski CM, Reichelderfer M, Torrealba J, Weichen J et al. Target-selected Apc-mutant rat kindred enhances the modeling of familial human colon cancer. Proc Natl Acad Sci U S A 2007; 104: 4036-4
27. Anisimov VN, Ukraintseva SV, Yashin AI. Cancer in rodents: does it tell us about cancer in humans? Nat Rev Cancer 2005; 5: 807-19
28. Takahashi M, Mutoh M, Kawamori T, Sugimura T, Wakabayashi K. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis. Carcinogenesis 2000; 21: 1319-27
29. Femia AP, Bendinelli B, Giannini A, Salvadori M, Pinzani P, Dolara P et al. Mucin-depleted foci have 13-catenin gene mutations, altered expression of its protein, and are dose- and time-dependent in the colon of 1,2-dimethylhydrazine-treated rats. Int J Cancer 2005; 116: 9-15
30. Yamada Y, Yoshimi N, Hirose Y, Kawabata K, Matsunaga K, Shimizu M et al. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Cancer Res 2000; 60: 3323-7
31. Femia AP, Tarquini E, Salvadori M, Fern S, Giannini A, Dolara P et al. K-ras mutations and mucin profile in preneoplastic lesions and colon tumors induced in rats by 1,2-dimethylhydrazine. Int J Cancer 2008; 122: 117-23
32. Corpet DE, Tache S. Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency. Nutr Cancer 2002; 43: 1-21
33. LaMont JT, O'Gorman TA. Experimental colon cancer. Gastroenterology 1978; 75: 1157-69
34. Chang WW. Histogenesis of colon cancer in experimental animals. Scand J Gastroenterol 1984; 104: 27-43
35. Glauert HP, Weeks JA. Dose- and time-response of colon carcinogenesis in Fischer-344 rats after a single dose of 1,2-dimethylhydrazine. Toxicol Lett 1989; 48: 283-7
36. Ready BS, Maeura Y. Tumor promotion by dietary fat in azoxymethane-induced colon carcinogenesis in female F344 rats: influence of amount and source of dietary fat. J Natl Cancer Inst 1984; 72: 745-50
37. Femia AP, Caderni G, Ianni M, Salvadori M, Schijlen E, Collins G et al. Effect of diets fortified with tomatoes or onions with variable quercetin-glycoside content on azoxymethane-induced aberrant crypt foci in the colon of rats. Eur J Nutr 2003; 42: 346-52
38. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003; 3: 768-80
39. Sohn OS, Fiala ES, Requeijo SP, Weisburger JH, Gonzalez FJ. Differential effects of CYP2E1 status on the metabolic activation of the colon carcinogens azoxymethane and methylazoxymethanol. Cancer Res 2001; 61: 8435-40
40. Day DW, Jass JR, Price AB, Shepherd NA, Sloan JM, Talbot IC et al. Morson and Dawson's gastrointestinal pathology, 4th edition. Oxford: Blackwell Publishing; 2003
41. Sugimura T. Nutrition and dietary carcinogens. Carcinogenesis 2000; 21: 387-95
42. Nakagama H, Nakanishi M, Ochiai M. Modeling human colon cancer in rodents using a food-borne carcinogen, PhIP. Cancer Sci 2005; 96: 627-36
43. Maurin N, Forgue-Lafitte ME, Levy P, Zimber A, Bara J. Progression of tumors arising from large ACF is associated with the MUC5AC expression during rat colon MNNG carcinogenis. Int J Cancer 2007; 120: 477-83
44. Clapper ML, Cooper HS, Chang WC. Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions. Acta Pharmacol Sin 2007; 28: 1450-9
45. Kern SE, Redston M, Seymour AB, Caldas C, Powell SM, Kornacki S et al. Molecular genetic profiles of colitis-associated neoplasms. Gastroenterology 1994; 107: 420-8
46. Tartaka T, Kohno H, Suzuki R, Yamada Y, Sugie S, Mori H. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci 2003; 94: 965-73
47. Neufert C, Becker C, Neurath MF. An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat Prot 2007; 2: 1998-2004
48. Kohno H, Suzuki R, Curini M, Epifano F, Maltese F, Gonzales SP et al. Dietary administration with prenyloxycoumarins, auraptene and collinin, inhibits colitis-related colon carcinogenesis in mice. Int J Cancer 2006; 118: 2936-42
49. Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 1987; 37: 147-51
50. Pretlow TP, Pretlow TG. Mutant KRAS in aberrant crypt foci (ACF): initiation of colorectal cancer? Biochim Biophys Acta 2005; 1756: 83-96
51. Di Gregorio C, Losi L, Fante R, Modica S, Ghidoni M, Pedroni M et al. Histology of aberrant crypt foci in the human colon. Histopathology 1997; 30: 328-34
52. Zheng Y, Kramer PM, Lubet RA, Steele VE, Kelloff GJ, Pereira MA. Effect of retinoids on AOM-induced colon cancer in rats: modulation of cell proliferation, apoptosis and aberrant crypt foci. Carcinogenesis 1999; 20: 255-60
53. Shift CK, Chiang W, Kuo ML. Effects of adlay on azoxymethane-induced colon carcinogenesis in rats. Food Chem Toxicol 2004; 42: 1339-47
54. Papanikolaou A, Wang QS, Papanikolaou D, Whiteley HE, Rosenberg DW. Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis. Carcinogenesis 2000; 21: 1567-72
55. Hayashi K, Suzuki R, Miyamoto S, Shin-Ichiroh Y, Kohno H, Sugie S et al. Citrus auraptene suppresses azoxymethane-induced colonic preneo-plastic lesions in C57BL/KsJ-db/db mice. Nutr Cancer 2007; 58: 75-84
56. Asano N, Kuno T, Hirose Y, Yamada Y, Yoshida K, Tomita H et al. Preventive effects of a flavonoid myricitrin on the formation of azoxyme-thane-induced premalignant lesions in colons of rats. Asian Pac J Cancer Prev 2007; 8: 73-6
57. Ochiai M, Watanabe M, Nakanishi M, Taguchi A, Sugimura T, Nakagama H. Differential staining of dysplastic aberrant crypt foci in the colon facilitates prediction of carcinogenic potentials of chemicals in rats. Cancer Lett 2005; 220: 67-74
58. Caderni G, Femia AP, Giannini A, Favuzza A, Luceri C, Salvadori M et al. Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis. Cancer Res 2003; 63: 2388-92
59. Femia AP, Dolara P, Caderni G. Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis. Carcinogenesis 2004; 25: 277-81
60. Femia AP, Dolara P, Giannini A, Salvadori M, Biggeri A, Caderni G. Frequent mutation of Apc gene in rat colon tumors and mucin-depleted foci, preneoplastic lesions in experimental colon carcinogenesis. Cancer Res 2007; 67: 445-9
61. Femia AP, Caderni G, Bottini C, Salvadori M, Dolara P, Tessitore L. Mucin-depleted foci are modulated by dietary treatments and show deregulation of proliferative activity in carcinogen-treated rodents. Int J Cancer 2007; 120: 2301-5
62. Plate AY, Gallaher DD. Effects of indoIe-3-carbinol and phenethyl isothiocyanate on colon carcinogenesis induced by azoxymethane in rats. Carcinogenesis 2006; 27: 287-92
63. Pierre F, Santarelli R, Taché S, Guéraud F, Corpet DE. Beef meat promotion of dimethylhydrazine-induced colorectal carcinogenesis biomarkers is suppressed by dietary calcium. Br J Nutr 2008; 99: 1000-6
64. Arikawa AY, Gallaher DD. Cruciferous vegetables reduce morphological markers of colon cancer risk in dimethylhydrazine-treated rats. J Nutr 2008; 138: 526-32